Cancer is a life-threatening disease and one of the leading causes of death worldwide. While there have been significant advances in treating cancer, it is still widely recognized as a leading area of unmet medical needs.

We have both clinical and pre-clinical programs underway to develop leading, novel, molecular targeted cancer therapies. Our discovery research is focused on specific oncology targets with a full panel of in vitro and in vivo assays. Multiple compounds are being pursued at different pre-clinical/discovery/development stages.